Advancements in Clinical Research and Development of Obesity Treatment Medications Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination Cagrilintide Appetite Suppression & Metabolic Control What is cagrilintide (glucagon like peptide 1 receptor agonist) used for in the management of type 2 diabetes and obesity? Structural and dynamic features of cagrilintide binding to calcitonin and amylin receptors Nature Communications cagrilintide